Alliance Advocates for Equitable Access for Alzheimer's Patients Seeking New Treatment

WASHINGTON, March 18 (TNStalk) -- The Alliance for Aging Research issued the following statement on March 17, 2023:

* * *

The Institute for Clinical and Economic Review (ICER) held a meeting today to discuss Leqembi (lecanumab), an FDA-approved treatment that slows cognitive decline in patients with early-onset Alzheimer's disease. Alliance President & CEO Sue Peschin, MHS, gave public comment during the meeting:

Hello, everyone. I'm Sue Peschin. I serv . . .

To gain access to full content fill out the form below.

Information Request Form

I'd like more information
Sign me up for a free trial

Name:
Newspaper/Company:
Email:
Phone:
State:
Keywords or Areas of Interest:

Select Product(s) you are interested in:
Daily Federal Tipoffs for your City/State
Congressional Vote Chart
Federal Contract Awards
Federal Patent Awards
News Releases from Federal Agencies
News Releases from States
News Releases from Counties
News Releases from Cities
Golf Handicap site (FairwayFiles.com)

Filling out this form will generate a contact, by phone or e-mail, from a TNS editor. No automated information is provided. How would you like to be contacted: Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial